Brought to you by:
Stent maintenance: Sustaining long-term patency in deep venous system
This advertorial is sponsored by Stryker/Inari Medical. As venous stenting becomes more common, the focus must now shift to what occurs after the procedure, according to consultant vascular surgeon Stephen Black, MD, FRCS. The concept of stent maintenance is key,…
Mechanical thrombectomy system for AV access shows promise, study shows
A retrospective analysis of 64 patients treated between 2022 and 2025 using a novel mechanical thrombectomy system to treat dialysis access thrombus showed function was restored in 91% of those treated. Data from the study of the InThrill system (Stryker/…
When to re-intervene: Stent surveillance and the effective use of RevCore mechanical thrombectomy to clear in-stent thrombosis
This advertorial is sponsored by Stryker/Inari Medical. How a finely tuned stent surveillance program plays a crucial role in raising the alarm of worsening symptoms in DVT patients and identifies those who might require reintervention with mechanical thrombectomy. For Jake…
Inari Medical, now part of Stryker, launches InThrill thrombectomy system
Inari Medical—now part of Stryker—has announced the launch of its next-generation InThrill thrombectomy system. The company stated in a recent press release that this is the “first and only purpose-built” small vessel and arteriovenous (AV) access thrombectomy system that can…
Inari Medical, now part of Stryker, launches Artix thrombectomy system
Inari Medical, now part of Stryker, recently announced the launch of its Artix thrombectomy system. Purpose-built for the needs of the peripheral arterial system, Artix is a combined aspiration plus mechanical thrombectomy solution. Stryker notes that the Artix system builds…
Stryker completes acquisition of Inari Medical
Stryker announced today that it has completed the acquisition of Inari Medical. A press release notes that the addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing venous thromboembolism (VTE) segment. “The acquisition of Inari…
Deep vein arterialization: Much remains to be learned but use poised to expand in patients with less severe ischemia
These remain early days for transcatheter arterialization of the deep veins (TADV) in the setting of patients with severe chronic limb-threatening ischemia (CLTI), says Daniel Clair, MD, one of the principal investigators in key clinical trials of the procedure, but…
How the RevCore and VenaCore thrombectomy catheters combine to broaden treatment approach among advanced deep vein thrombosis patients previously limited to few options
This advertorial is sponsored by Inari Medical. For Joseph M. Liechty, MD, a vascular surgeon with Texas Vascular Associates in Plano, Texas, the emergence of the RevCoreTM and VenaCoreTM devices (Inari Medical) have helped broaden his treatment strategies for advanced…
VenaCore device offers long-awaited interventional solution for challenging venous occlusions
This advertorial is sponsored by Inari Medical. Despite the recent growth in mechanical thrombectomy devices for acute deep vein thrombosis (DVT), interventional options for wall adherent venous obstruction are extremely limited. Residual venous obstruction after medical or interventional therapy for…
Inari Medical updates ClotTriever XL IFU amid FDA recall notice
The Food and Drug Administration (FDA) has issued a Class I recall—the most serious type—for Inari Medical‘s ClotTriever XL, 30mm device due to reports of patient injury, and death from device entrapment and pulmonary emboli (PE). The device remains on…